Swiss Chems Provider Profile Name: Swiss Chems Website: swisschems.com Founded: August 2018 Provider Type: Research Peptide Vendor FDA Warning Letter: December 10, 2024 Operating Details E-commerce peptide vendor Received an FDA warning letter in December 2024 after an investigation found the company was selling semaglutide and retatrutide products for human use despite marketing them for research and chemical purposes No prescription required for purchase Products sold as freeze-dried powders requiring reconstitution About the Company Swiss Chems was among the companies targeted in the FDAs December 2024 enforcement wave, alongside Xcel Peptides, Summit Research, and Prime Peptides, all found to be selling semaglutide, tirzepatide, and/or retatrutide for human use despite marketing the drugs for research and chemical purposes
Focus on nutrient-dense, electrolyte-rich foods: Leafy greens: Spinach, kale, and Swiss chard provide potassium and magnesium Avocados: Rich in potassium and healthy fats for satiety Bone broth: Natural sodium, minerals, and easy to digest Salmon and fatty fish: Protein, omega-3s, and trace minerals Nuts and seeds: Magnesium, healthy fats, and satisfying texture Greek yogurt: Protein, calcium, and potassium (if dairy is tolerated) Pair these foods with your electrolyte drinks for comprehensive mineral coverage
Resources We Trust Mayo Clinic: The Reality of Menopause Weight Gain NewYork-Presbyterian: Women in Menopause Benefit From GLP-1 Weight-Loss Medications as Much as Younger Women Menopause Diet: What to Eat to Help Manage Symptoms Cleveland Clinic: UCLA Health: The Best Way to Work Out After Menopause How Risky Are Weight Loss Drugs for Older Adults
2004 Jun;286(6):E916-26
